Every ingredient entered by hand against the primary literature. 3,862 so far, each with its trail of citations.
Doses checked against what the trials actually used, forms against what was actually studied, labels against both.
For brands, independent lab results read line by line against the label. Labs test. IngredientMD verifies. If it fails, no badge.
Where the intelligence comes from.
Sources are cited by name: PubMed / NIH, ClinicalTrials.gov, Semantic Scholar, SUPP.AI and the rest of the 10 primary databases below. None of them endorse IngredientMD or any product, and the citations are the point.
How a formula becomes a record.
The formula is read against the trials and the interaction record, dose by dose, form by form. Nothing the label claims is taken on faith.
Papers on file are read for what they are. A certificate that states specifications is said to state specifications, nothing more. Labs test. IngredientMD verifies.
What holds up earns a verdict from the closed library and a public record. What does not hold up earns silence, never a warning label.
The verdict can't be bought or edited. Brands pay for display and tooling, never the outcome.
Private until you publish, and the fee pays for review time, never for the outcome.
Labs test. IngredientMD verifies. A lab result is evidence; the read of it against the label is the work.
Limit stamps say checked, never verified. A regulator publishes a number; the engine checks the label against it and says exactly that.
PUBLIC LIMITS · CHECKEDEvery public verdict comes from this list, three registers deep. The registers are claim types, not grades, and none is second place: Clinical sells strength, Precision sells fit, Emerging sells momentum. There is no negative word in the library, what doesn't hold up earns silence, never a warning label. The internal score still sorts the library and decides the register. It never speaks in public.
The engine reads everything and flags what needs a closer look. Corrections land at editorial@ingredientmd.com and get a same-week read.
